Immunomodulation by Mesenchymal Stem Cells
Reza Abdi(Brigham and Women's Hospital), Mohamed H. Sayegh(American University of Beirut), Chaker N. Adra(Brigham and Women's Hospital), Paolo Fiorina(Boston Children's Hospital), Mark A. Atkinson(University of Florida)
Cited by 470
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k